NDC 0469-6501 – Lexiscan

Regadenoson .08 mg/mL · Injection, Solution · Intravenous

Human Prescription Drug

Product NDC0469-6501

Product details

Brand name
Lexiscan
Generic name
Regadenoson
Labeler
Astellas Pharma US, Inc.
Dosage form
Injection, Solution
Route
Intravenous
Marketing category
NDA · NDA022161
Marketed since
April 10, 2008
Listing expires
December 31, 2026
Pharmacologic class
Adenosine Receptor Agonist

Active ingredients

Uses, dosage, side effects and warnings for Lexiscan →

Package NDC codes (1)

Package NDCDescriptionSince
0469-6501-895 mL in 1 SYRINGE, PLASTIC (0469-6501-89)Apr 10, 2008